{
    "clinical_study": {
        "@rank": "82246", 
        "arm_group": [
            {
                "arm_group_label": "no vasodilator", 
                "description": "patients receiving no vasodilator"
            }, 
            {
                "arm_group_label": "CCB", 
                "description": "patients receiving a calcium channel blocker (CCB) for digital vasculopathy"
            }, 
            {
                "arm_group_label": "i.v. prostanoids or PDE5i or ETRAs", 
                "description": "patients treated with i.v. prostanoids or phosphodiesterase-5 inhibitors (PDE5i) or endothelin receptor antagonists (ETRA), regardless of whether a calcium channel blocker is given in addition"
            }
        ], 
        "brief_summary": {
            "textblock": "Systemic sclerosis (SSc) is an orphan, multiorgan disease affecting the connective tissue of\n      the skin and several internal organs.\n\n      Pulmonary hypertension (PH) is a fatal disorder characterized by an increase in pulmonary\n      vascular resistance, which leads to right ventricular failure. Despite being recently the\n      object of greater attention and despite therapeutic advances, pulmonary hypertension due to\n      SSc remains associated with a dismal 47 - 67% 3-year survival. Among SSc patients\n      prospectively followed in the \"European League Against Rheumatism Scleroderma Trials and\n      Research\" (EUSTAR) cohort, 26% of death was related to pulmonary hypertension. Although some\n      previous data have suggested the protective effects of calcium channel blockers on the\n      development of pulmonary hypertension, the potential preventive effects of vasodilators for\n      the prevention of Pulmonary hypertension have not been determined yet. In addition to be\n      considered routinely for the treatment of SSc-related pulmonary hypertension, prostanoids,\n      endothelin receptor antagonists (ETRA) and Phosphodiesterase-5 inhibitors (PDE5i) can also\n      be used for this indication.\n\n      This observational trial is one out of five observational trials of the collaborative\n      project \"To decipher the optimal management of systemic sclerosis\" (DeSScipher).\n\n      Aim of this observational trial is:\n\n      -  to compare the outcomes of adult and juvenile SSc patients who are at high risk of\n      developing pulmonary hypertension and are receiving either different vasodilator treatments\n      or no vasodilator treatment."
        }, 
        "brief_title": "Development and Prevention of Pulmonary Hypertension in Systemic Sclerosis", 
        "completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Systemic Sclerosis", 
            "Pulmonary Hypertension"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypertension", 
                "Hypertension, Pulmonary", 
                "Scleroderma, Systemic", 
                "Scleroderma, Diffuse", 
                "Sclerosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Juvenile and adult Systemic sclerosis patients, with diagnosis according to the\n             ACR/EULAR adult SSc criteria and PRES/ACR/EULAR juvenile SSc criteria respectively\n\n          -  Patients at high risk of pulmonary hypertension with a Cochin Risk prediction score\n             >/= 3\n\n        ACR = American College of Rheumatology; EULAR = European League Against Rheumatism; PRES =\n        Pediatric Rheumatology European Society"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "The study population are adult and juvenile systemic sclerosis patients from the EUSTAR\n        cohort (MEDSonline database) and the juvenile systemic sclerosis working group cohort"
            }
        }, 
        "enrollment": {
            "#text": "960", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01840748", 
            "org_study_id": "HEALTH-F5-2012-305495-OT4"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Calcium Channel Blockers", 
                "Vasodilator Agents"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 23, 2013", 
        "link": {
            "url": "http://www.desscipher.eu"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75014"
                    }, 
                    "name": "Universit\u00e9 Paris Descartes, H\u00f4pital Cochin, Service de Rhumatologie A & INSERM 1016"
                }, 
                "investigator": {
                    "last_name": "Yannick Allanore, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bad Nauheim", 
                        "country": "Germany", 
                        "zip": "61231"
                    }, 
                    "name": "Justus-Liebig-University Gie\u00dfen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology"
                }, 
                "investigator": [
                    {
                        "last_name": "Ulf M\u00fcller-Ladner, Prof.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Ingo Tarner, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Marc Frerix, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "10117"
                    }, 
                    "name": "Charit\u00e9 Universit\u00e4tsmedizin Berlin, Charit\u00e9 Centrum 12 f\u00fcr Innere Medizin und Dermatologie, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie"
                }, 
                "investigator": {
                    "last_name": "Gabriela Riemekasten, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany", 
                        "zip": "22081"
                    }, 
                    "name": "Centre for Pediatric Rheumatology, Klinikum Eilbek"
                }, 
                "investigator": {
                    "last_name": "Ivan Foeldvari, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pecs", 
                        "country": "Hungary", 
                        "zip": "H-7622"
                    }, 
                    "name": "Pecsi Tudomanyegyetem - University of Pecs"
                }, 
                "investigator": {
                    "last_name": "Laszlo Czirjak, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy", 
                        "zip": "50139"
                    }, 
                    "name": "University of Florence, Denothe Centre, Division of Rheumatology AOUC, Department of Biomedicine"
                }, 
                "investigator": {
                    "last_name": "Marco Matucci-Cerinic, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Napoli-Italia", 
                        "country": "Italy", 
                        "zip": "5-80131"
                    }, 
                    "name": "Policlinico, Via Pansini"
                }, 
                "investigator": {
                    "last_name": "Gabriele Valentini, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Basel", 
                        "country": "Switzerland", 
                        "zip": "CH 4012 Basel"
                    }, 
                    "name": "Felix-Platter Spital, University of Basel"
                }, 
                "investigator": {
                    "last_name": "Ulrich Walker, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zurich", 
                        "country": "Switzerland", 
                        "zip": "8006"
                    }, 
                    "name": "University of Zurich, Department of Rheumatology"
                }, 
                "investigator": {
                    "last_name": "Oliver Distler, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leeds", 
                        "country": "United Kingdom", 
                        "zip": "LS9 7TF"
                    }, 
                    "name": "The Universitiy of Leeds, Division of Rheumatic and Musculoskeletal Disease, St James's University Hospital"
                }, 
                "investigator": {
                    "last_name": "Francesco Del Galdo, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "NW3 2QG"
                    }, 
                    "name": "Royal Free Hospital, University College London"
                }, 
                "investigator": {
                    "last_name": "Christopher Denton, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Germany", 
                "Hungary", 
                "Italy", 
                "Switzerland", 
                "United Kingdom"
            ]
        }, 
        "number_of_groups": "3", 
        "overall_contact": {
            "email": "yannick.allanore@cch.aphp.fr", 
            "last_name": "Yannick Allanore, Prof."
        }, 
        "overall_contact_backup": {
            "email": "javouac@yahoo.fr", 
            "last_name": "J\u00e9rome Avouac, Prof."
        }, 
        "overall_official": [
            {
                "affiliation": "Universit\u00e9 Paris Descartes, H\u00f4pital Cochin, Service de Rhumatologie A & INSERM 1016", 
                "last_name": "Yannick Allanore, Prof.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Justus-Liebig-University Gie\u00dfen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology", 
                "last_name": "Ulf M\u00fcller-Ladner, Prof.", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Italy: Ethics Committee", 
                "Germany: Ethics Commission", 
                "Hungary: Institutional Ethics Committee", 
                "France: Institutional Ethical Committee", 
                "Switzerland: Ethikkommission", 
                "United Kingdom: Research Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The number of patients with pulmonary hypertension at 2 years", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01840748"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Paris 5 - Rene Descartes", 
            "investigator_full_name": "Yannick ALLANORE", 
            "investigator_title": "Prof. Yannik Allanore", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "participants will be followed for the duration of 2 years, the time until development of precapillary pulmonary hypertension is the secondary outcome", 
            "measure": "Time to development of precapillary pulmonary hypertension", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "University of Paris 5 - Rene Descartes", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "European Union", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Giessen", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Zurich", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Florence", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Second University of Naples", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Basel", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University College, London", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Charite University, Berlin, Germany", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Pecs", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Leeds", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Schoen Klinik Hamburg Eilbek", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Paris 5 - Rene Descartes", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "2 Years", 
        "verification_date": "April 2013"
    }
}